RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis

ConclusionsRASSF1A promoter methylation may be associated with cervical cancer development, progression and metastasis. MethylatedRASSF1A may be a noninvasive blood or cytology biomarker. Based on TSA, more studies are essential in the future.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research